Cytotherapy 2013
Peripheral blood-derived autologous stem cell therapy for the treatment of patients with late-stage peripheral artery disease-results of the short- and long-term follow-up
G.V. Szabó, Z. Kövesd, J. Cserepes, J. DaróczyM. Belkin M, and G. Acsády
BioProcessing Journal 2007
Challenges in the Development of Autologous Cell Therapy Products
Y. Porat, D. Belkin, A. Belleli, J. Elkayam, D. Shimoni, S. Porozov, I. Sarel, I. Ash, and V. Fulga
Hemostemix ACP-01 Publication
Autologous Stem Cell Treatment For CLI Patients With No Revascularization Options
(An Update of the Hemostemix ACP-01 Trial With 4.5 Year Followup)
Jonathan Misskey MD MHPE FRCSC, Lynn Cunada, RN, Kyle Makofka, Alan Jacobs MSEE MD PhD,
Thomas Lindsay MDCM, MSc, FRCSC, York N. Hsiang, MB ChB, MHSc., FRCSCS